These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Altered molecular specificity of surfactant phosphatidycholine synthesis in patients with acute respiratory distress syndrome. Dushianthan A; Goss V; Cusack R; Grocott MP; Postle AD Respir Res; 2014 Nov; 15(1):128. PubMed ID: 25378080 [TBL] [Abstract][Full Text] [Related]
3. Patients with ARDS show improvement but not normalisation of alveolar surface activity with surfactant treatment: putative role of neutral lipids. Markart P; Ruppert C; Wygrecka M; Colaris T; Dahal B; Walmrath D; Harbach H; Wilhelm J; Seeger W; Schmidt R; Guenther A Thorax; 2007 Jul; 62(7):588-94. PubMed ID: 17287298 [TBL] [Abstract][Full Text] [Related]
4. Surfactant phospholipids, surfactant proteins, and inflammatory markers during acute lung injury in children. Todd DA; Marsh MJ; George A; Henderson NG; Barr H; Sebastian S; Clark GT; Koster G; Clark HW; Postle AD Pediatr Crit Care Med; 2010 Jan; 11(1):82-91. PubMed ID: 19550365 [TBL] [Abstract][Full Text] [Related]
5. Alteration of fatty acid profiles in different pulmonary surfactant phospholipids in acute respiratory distress syndrome and severe pneumonia. Schmidt R; Meier U; Yabut-Perez M; Walmrath D; Grimminger F; Seeger W; Günther A Am J Respir Crit Care Med; 2001 Jan; 163(1):95-100. PubMed ID: 11208632 [TBL] [Abstract][Full Text] [Related]
6. Time-dependent changes in pulmonary surfactant function and composition in acute respiratory distress syndrome due to pneumonia or aspiration. Schmidt R; Markart P; Ruppert C; Wygrecka M; Kuchenbuch T; Walmrath D; Seeger W; Guenther A Respir Res; 2007 Jul; 8(1):55. PubMed ID: 17662121 [TBL] [Abstract][Full Text] [Related]
8. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Günther A; Siebert C; Schmidt R; Ziegler S; Grimminger F; Yabut M; Temmesfeld B; Walmrath D; Morr H; Seeger W Am J Respir Crit Care Med; 1996 Jan; 153(1):176-84. PubMed ID: 8542113 [TBL] [Abstract][Full Text] [Related]
9. Pulmonary surfactant subfractions in patients with the acute respiratory distress syndrome. Veldhuizen RA; McCaig LA; Akino T; Lewis JF Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):1867-71. PubMed ID: 8520748 [TBL] [Abstract][Full Text] [Related]
10. Secretory phospholipase A2-mediated depletion of phosphatidylglycerol in early acute respiratory distress syndrome. Seeds MC; Grier BL; Suckling BN; Safta AM; Long DL; Waite BM; Morris PE; Hite RD Am J Med Sci; 2012 Jun; 343(6):446-51. PubMed ID: 22173044 [TBL] [Abstract][Full Text] [Related]
11. Pulmonary surfactant in patients with Pneumocystis pneumonia and acquired immunodeficiency syndrome. Schmidt R; Markart P; Ruppert C; Temmesfeld B; Nass R; Lohmeyer J; Seeger W; Günther A Crit Care Med; 2006 Sep; 34(9):2370-6. PubMed ID: 16849999 [TBL] [Abstract][Full Text] [Related]
12. Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome. Spragg RG; Gilliard N; Richman P; Smith RM; Hite RD; Pappert D; Robertson B; Curstedt T; Strayer D Chest; 1994 Jan; 105(1):195-202. PubMed ID: 8031347 [TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor acetylhydrolase is increased in lung lavage fluid from patients with acute respiratory distress syndrome. Grissom CK; Orme JF; Richer LD; McIntyre TM; Zimmerman GA; Elstad MR Crit Care Med; 2003 Mar; 31(3):770-5. PubMed ID: 12626982 [TBL] [Abstract][Full Text] [Related]
14. Selective medicated (normal saline and exogenous surfactant) bronchoalveolar lavage in severe aspiration syndrome in children. Marraro GA; Luchetti M; Spada C; Galassini E; Giossi M; Piero AM Pediatr Crit Care Med; 2007 Sep; 8(5):476-81. PubMed ID: 17693914 [TBL] [Abstract][Full Text] [Related]
15. Pulmonary surfactant composition early in development of acute lung injury after cardiopulmonary bypass: prophylactic use of surfactant therapy. Haslam PL; Baker CS; Hughes DA; MacNaughton PD; Moat NE; Dewar A; Aggarwal A; Evans TW Int J Exp Pathol; 1997 Aug; 78(4):277-89. PubMed ID: 9505939 [TBL] [Abstract][Full Text] [Related]
16. Activin-A overexpression in the murine lung causes pathology that simulates acute respiratory distress syndrome. Apostolou E; Stavropoulos A; Sountoulidis A; Xirakia C; Giaglis S; Protopapadakis E; Ritis K; Mentzelopoulos S; Pasternack A; Foster M; Ritvos O; Tzelepis GE; Andreakos E; Sideras P Am J Respir Crit Care Med; 2012 Feb; 185(4):382-91. PubMed ID: 22161160 [TBL] [Abstract][Full Text] [Related]
17. Elevated transforming growth factor-alpha levels in bronchoalveolar lavage fluid of patients with acute respiratory distress syndrome. Madtes DK; Rubenfeld G; Klima LD; Milberg JA; Steinberg KP; Martin TR; Raghu G; Hudson LD; Clark JG Am J Respir Crit Care Med; 1998 Aug; 158(2):424-30. PubMed ID: 9700116 [TBL] [Abstract][Full Text] [Related]
18. Impact of C-reactive protein (CRP) on surfactant function. Li JJ; Sanders RL; McAdam KP; Hales CA; Thompson BT; Gelfand JA; Burke JF J Trauma; 1989 Dec; 29(12):1690-7. PubMed ID: 2593200 [TBL] [Abstract][Full Text] [Related]
19. Contrast media inhibit exogenous surfactant therapy in rats with acute respiratory distress syndrome. Kesecioglu J; Haitsma JJ; Schultz MJ; den Heeten GJ; Lachmann B Clin Physiol Funct Imaging; 2006 Mar; 26(2):120-6. PubMed ID: 16494603 [TBL] [Abstract][Full Text] [Related]
20. The adult respiratory distress syndrome: first trials with surfactant replacement. Richman PS; Spragg RG; Robertson B; Merritt TA; Curstedt T Eur Respir J Suppl; 1989 Mar; 3():109s-111s. PubMed ID: 2742681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]